primary endpoint analysis of the geparduo study comparing dose-dense with sequential adriamycindocetaxel combination as preoperative chemotherapy (pcht) in operable breast cancer (t2-3, ..
本文档由 ept074490 分享于2017-03-16 14:05
primary endpoint analysis of the geparduo study comparing dose-dense with sequential adriamycindocetaxel combination as preoperative chemotherapy (pcht) in operable breast cancer (t2-3, n0-2, m0)
下载文档
收藏
打印
分享：
君，已阅读到文档的结尾了呢~~